Aussie radiopharma company Advancell Co. Ltd. unveiled promising early clinical data that could redefine how advanced ...

In a world where cancer remains a formidable adversary, Mr Z's story serves as a poignant reminder of the importance of early intervention and the power of patient awareness. Don’t let the silence of ...

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

Injecting poly-ICLC directly into prostate tumors before surgery may reawaken immune activity and help transform resistant ...

Prostate cancers occur across a wide spectrum, ranging from highly aggressive and life-threatening tumours to relatively ...

The European Society for Medical Oncology(ESMO) Congress 2025 in Berlin (17–21 October) delivered a week of consequential but not always uniform readouts. Antibody-drug conjugates (ADCs) stayed in the ...

Combining enzalutamide with standard hormone therapy cut the risk of prostate cancer death by over 40% in a clinical trial The treatment targeted patients whose prostate cancer recurred aggressively ...

Former President Joe Biden has completed a course of radiation therapy after being diagnosed in May with an "aggressive form" of prostate cancer, according to a spokesperson. Biden's daughter Ashley ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, lowering the risk of death after eight years by 40.3%. What's more, the drug ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

Scientists based in Australia and China have identified a pair of pesky enzymes responsible for prolonging prostate cancer – which means we can potentially target them for quicker and more effective ...